Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital

Chuo-ku, Sapporo-shi, Hokkaido 060-0033

0 studies enrolling now · 2 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Running, not enrolling
• A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease — Completed